Heartland Bank & Trust’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$477K Sell
7,594
-1,682
-18% -$135K 0.11% 131
2025
Q4
$884K Sell
9,276
-158
-2% -$15.5K 0.37% 54
2025
Q3
$921K Sell
9,434
-40
-0.4% -$4.14K 0.38% 58
2025
Q2
$1.02M Sell
9,474
-233
-2% -$23.6K 0.48% 44
2025
Q1
$979K Buy
9,707
+823
+9% +$82.9K 0.5% 44
2024
Q4
$794K Sell
8,884
-1,054
-11% -$92.8K 0.43% 51
2024
Q3
$833K Sell
9,938
-358
-3% -$28.2K 0.45% 46
2024
Q2
$793K Sell
10,296
-1,883
-15% -$138K 0.45% 43
2024
Q1
$834K Sell
12,179
-1,027
-8% -$66K 0.48% 47
2023
Q4
$763K Sell
13,206
-665
-5% -$35.5K 0.53% 48
2023
Q3
$732K Buy
13,871
+223
+2% +$11.7K 0.58% 45
2023
Q2
$738K Sell
13,648
-1,493
-10% -$78K 0.58% 44
2023
Q1
$758K Buy
+15,141
New +$714K 0.57% 48

Other funds holding BSX

Heartland Bank & Trust's BSX Position: Q1 2026 in Review

Heartland Bank & Trust reduced its Boston Scientific (BSX) stake by 18% in Q1 2026, selling an estimated $135K and leaving 7,594 shares worth $477K. The position accounts for 0.11% of the portfolio, ranked #131.

Heartland Bank & Trust first reported a position in BSX in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.02M in Q2 2025. 1,667 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Heartland Bank & Trust held 7,594 shares of Boston Scientific worth $477K as of Q1 2026.
  • Heartland Bank & Trust sold 1,682 Boston Scientific shares in Q1 2026, an estimated $135K.
  • Boston Scientific made up 0.11% of Heartland Bank & Trust's portfolio in Q1 2026, its #131 holding.
  • Heartland Bank & Trust first reported a position in Boston Scientific in Q1 2023 and has held it in 13 quarters since.
  • Heartland Bank & Trust's Boston Scientific position peaked at $1.02M in Q2 2025.
  • 1,667 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Heartland Bank & Trust's 13F filing for Q1 2026, filed 6 May 2026.